A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer

NCT01373164 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Neoplasm Metastasis
Pancreatic Cancer

Interventions

DRUG: Galunisertib
DRUG: Gemcitabine
DRUG: Placebo

Sponsor

Eli Lilly and Company